Summary

This episode covers the latest developments in markets, biotech innovations like GLP-1 generics, SpaceX IPO, and the impact of AI on society. It offers insights into investing, healthcare, and technological advancements shaping the future.

Chapters

00:00 Market and SpaceX News Overview

01:11 Healthcare Updates: GLP-1 and Infectious Diseases

02:20 Copper Peptides and Beauty Trends

03:04 Charity Event: Rethink Breast Cancer

05:02 Dog Emergency and GLP-1 Generics in Canada

06:26 Canada's First Generic GLP-1 Drugs

08:54 Pharmaceutical Industry and Sales Reps

11:00 Weight Loss Drugs and Body Image

14:27 Eating Disorders and Drug Safety

17:48 Canadian Economy and Consumer Spending

20:29 Retail Trends and Consumer Behavior

22:30 Investing in Retail and Luxury Brands

26:06 Market Trends: US and Canadian Economies

28:00 Interest Rates, Inflation, and Market Outlook

29:17 Starting Investment Early: Pay Yourself First

33:16 Retta Truetide Trial: Weight Loss Breakthrough

36:32 Safety and Efficacy of New Weight Loss Drugs

43:32 SpaceX IPO: Market Potential and Elon Musk

45:37 SpaceX's Satellite and Space Infrastructure

49:21 AI Impact on Society and Companies

52:23 AI Failures and Challenges in Social Media

55:24 Nvidia's AI Chip Success and Market Growth

Host descriptions:

Catherine Murray, a business newscaster and former Wall Street professional at Goldman, William Blair and Deutsche bank.

Dr. Melissa Hershberg, a medical practitioner with a specialized interest in preventive health, weight loss and aesthetic medicine.

Disclaimer: for entertainment purposes only, please do your own research, your own homework and consult with a financial advisor for investment discussions. In addition to consulting with your Family Doctor, Physician, GP or other health care providers before making any health and beauty decisions.

If you would like to join our email list, please reach out to contactgettinsavvy@gmail.com and let us know.